News
The impact of the global tariffs war will cost GE Healthcare Technologies Inc. around $500 million in 2025 at current rates, ...
The three stocks listed here below all pay more than a 3% dividend yield. Many stocks have been falling this year, and if you ...
Germany's Merck KGaA has struck a deal to buy U.S. biotech company SpringWorks Therapeutics for an equity value of $3.9 ...
Albert Bourla said Pfizer is being "frugal" with investments because of the uncertainty surrounding tariffs.
Merck announced on Tuesday that it is investing $1 billion in a new Delaware plant to expand domestic production as it ...
5hon MSN
We recently published a list of Billionaire Cliff Asness’ 10 Stock Picks with Huge Upside Potential. In this article, we are ...
Germany’s Merck KGaA has agreed to acquire U.S. biotech SpringWorks Therapeutics for $3.9 billion. The acquisition, aimed at ...
Merck & Co. Inc. managers escaped allegations that they hurt the pharmaceutical giant by misleading investors over traction ...
The pharmaceutical giant will invest $1 billion in a Delaware plant to manufacture Keytruda, as drugmakers ramp up U.S.
Merck & Co. will grow its U.S. manufacturing footprint with a $1 billion plant in Delaware, becoming the latest drugmaker to ...
MIAMI, April 30, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2025. Highlights from the first quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results